Suresh Pola

778 total citations
27 papers, 386 citations indexed

About

Suresh Pola is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Suresh Pola has authored 27 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Suresh Pola's work include Inflammatory Bowel Disease (14 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Suresh Pola is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Microscopic Colitis (10 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Suresh Pola collaborates with scholars based in United States, India and Canada. Suresh Pola's co-authors include William J. Sandborn, Elisabeth Evans, Barrett G. Levesque, Guillaume Bouguen, Jesús Rivera–Nieves, John P. Kirwan, K. D. Buchanan, John T. Chang, Elisabeth C. McLemore and Michael J. Docherty and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Suresh Pola

27 papers receiving 380 citations

Peers

Countries citing papers authored by Suresh Pola

Since Specialization

Citations

This map shows the geographic impact of Suresh Pola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Pola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Pola more than expected).

Fields of papers citing papers by Suresh Pola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Pola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Pola. The network helps show where Suresh Pola may publish in the future.

Co-authorship network of co-authors of Suresh Pola

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Pola. A scholar is included among the top collaborators of Suresh Pola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Pola. Suresh Pola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes 2021 ·Bioorganic & Medicinal Chemistry ·Suresh Pola, Shailesh R. Shah, (unknown), (unknown), (unknown), (unknown), (unknown), Debdutta Bandyopadhyay, Akshyaya Rath, Suresh Giri, (unknown), Ramchandra Ranvir, Sugantha Sundar, Harilal Patel, Jeevan Kumar, Mukul R. Jain	12
2	Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States 2021 ·Crohn s & Colitis 360 ·(unknown), Fernando Velayos, Fang Niu, Vincent Liu, Thomas Delate, Suresh Pola, (unknown), Rita L. Hui	3
3	Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort Study 2020 ·BioDrugs ·(unknown), Fang Niu, Suresh Pola, Fernando Velayos, Xian Ning, Rita L. Hui	15
4	Sa1872 IMMUNOGENICITY OF TUMOR NECROSIS FACTOR ANTAGONISTS AND THE EFFECT OF DOSE ESCALATION TO IMPROVE DRUG CONCENTRATIONS AND ELIMINATE ANTIBODIES IN A LARGE INFLAMMATORY BOWEL DISEASE POPULATION 2020 ·Gastroenterology ·Robert Battat, Ellen Scherl, Suresh Pola, Dana J. Lukin, Anand Kumar, Lauren Okada, (unknown), Anjali Jain, Corey A. Siegel	1
5	Opportunities for Improvement in the Care of Patients Hospitalized for Inflammatory Bowel Disease-Related Colitis 2016 ·Digestive Diseases and Sciences ·(unknown), Suresh Pola, Erik J. Groessl, Jesús Rivera–Nieves, Samuel B. Ho	15
6	Validation of Gene Expression Biomarker Analysis for Biopsy-based Clinical Trials in Crohnʼs Disease 2015 ·Inflammatory Bowel Diseases ·Brigid S. Boland, David L. Boyle, William J. Sandborn, Gary S. Firestein, Barrett G. Levesque, (unknown), Bing Zhang, (unknown), Lars Eckmann, Peter B. Ernst, Jesús Rivera–Nieves, Suresh Pola, (unknown), Guangyong Zou, John T. Chang	6
7	Validated gene expression biomarker analysis for biopsy‐based clinical trials in ulcerative colitis 2014 ·Alimentary Pharmacology & Therapeutics ·Brigid S. Boland, (unknown), William J. Sandborn, Gary S. Firestein, Barrett G. Levesque, (unknown), Bing Zhang, (unknown), Lars Eckmann, Peter B. Ernst, Jesús Rivera–Nieves, Suresh Pola, (unknown), John T. Chang	8
8	Transanal Endoscopic Surgical Proctectomy for Proctitis Case Series Report: Diversion, Radiation, Ulcerative Colitis, and Crohnâ€™s Disease 2013 ·Elisabeth C. McLemore, Hyuma A. Leland, Bikash Devaraj, Suresh Pola, Michael J. Docherty, Derek Patel, (unknown), William J. Sandborn, Mark A. Talamini, Sonia Ramamoorthy	3
9	Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Ulcerative Colitis 2013 ·Inflammatory Bowel Diseases ·Guillaume Bouguen, Barrett G. Levesque, Suresh Pola, Elisabeth Evans, William J. Sandborn	58
10	Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease 2013 ·Clinical Gastroenterology and Hepatology ·Guillaume Bouguen, Barrett G. Levesque, Suresh Pola, Elisabeth Evans, William J. Sandborn	104
11	Rectal cancer developing in the setting of a cavernous hemangioma of the rectosigmoid colon 2013 ·Gastrointestinal Endoscopy ·Suresh Pola, Elisabeth C. McLemore, Craig A. Munroe, Grace Lin, Cynthia Santillan, Thomas J. Savides, (unknown)	1
12	Outcomes of Computed Tomography and Magnetic Resonance Enterography in Clinical Practice of Inflammatory Bowel Disease 2013 ·Digestive Diseases and Sciences ·N. Patel, Suresh Pola, (unknown), Guangyong Zou, Cynthia Santillan, Derek Patel, Barrett G. Levesque, William J. Sandborn	16
13	Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Crohnʼs Disease 2013 ·The American Journal of Gastroenterology ·Guillaume Bouguen, (unknown), Suresh Pola, Elisabeth Evans, William J. Sandborn	1
14	Long-Term Risk of Cholangitis in Patients with Metal Stents for Malignant Biliary Obstruction 2012 ·Digestive Diseases and Sciences ·Suresh Pola, (unknown), Benjamin J. Cohen, Syed M. Abbas Fehmi, Thomas J. Savides	8
15	Su1921 Frequency and Yield of Computed Tomography (CT) Scan Imaging in the Emergency Department in Patients With Inflammatory Bowel Disease (IBD) 2012 ·Gastroenterology ·(unknown), Suresh Pola, William J. Sandborn, Derek Patel	1
16	Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis 2012 ·Clinical Gastroenterology and Hepatology ·Suresh Pola, (unknown), Sonia Ramamoorthy, Elisabeth C. McLemore, (unknown), Jesús Rivera–Nieves, John T. Chang, Elisabeth Evans, Michael J. Docherty, Mark A. Talamini, William J. Sandborn	46
17	Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Shailesh R. Shah, (unknown), (unknown), (unknown), Suresh Pola, (unknown), Priyanka Priyadarshini, (unknown), (unknown), (unknown), K Sairam, Suresh Giri, (unknown), Harilal Patel, (unknown), Hiren Patel, Mukul Jain, Pankaj Patel, Rajesh Bahekar	7
18	Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists 2010 ·Bioorganic & Medicinal Chemistry ·(unknown), Shailesh R. Shah, (unknown), (unknown), (unknown), Suresh Pola, (unknown), Priyanka Priyadarshini, (unknown), (unknown), Suresh Giri, Chitrang Trivedi, Mukul R. Jain, Pankaj Patel, Rajesh Bahekar	13
19	Design and synthesis of novel bis-oximinoalkanoic acids as potent PPARα agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mukul R. Jain, Shailesh R. Shah, (unknown), (unknown), Suresh Pola, (unknown), (unknown), Pravin Patil, Priyanka Priyadarshini, (unknown), (unknown), Suresh Giri, Pankaj Patel	3
20	The gastroenteroinsular response to glucose ingestion during postexercise recovery 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Suresh Pola, (unknown), (unknown), K. D. Buchanan, John P. Kirwan	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact